| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |